{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:06:41Z","timestamp":1790024801456,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study aimed to investigate the association between first-trimester Pregnancy-associated plasma protein A (PAPP-A) levels and subsequent gestational diabetes mellitus (GDM) development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>The study was conducted on 5854 pregnant women who attended routine prenatal care. Maternal biomarkers, including PAPP-A and free beta hCG, were measured for all women in a referral laboratory and converted to MoM values. Pregnant women were divided into two groups, based on the serum concentration of PAPP-A, (PAPP-A\u2009&gt;\u20090.4 (normal) and PAPP-A\u2009&lt;\u20090.4 (low)). Data on the screening test for GDM and pregnancy outcomes were collected and analyzed with appropriate tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Of the 5854 pregnant women, 889 (15.19%) developed GDM. The maternal PAPP-A MoM concentrations were significantly lower in GDM cases compared to controls. Indeed, gestational age at delivery and birth weight were significantly lower (p\u2009&lt;\u20090.001) in PAPP-A MoM\u2009&lt;\u20090.4, and the rate of intrauterine growth restriction (IUGR) was significantly higher (p\u2009&lt;\u20090.001). ROC analysis revealed that the sensitivity and specificity of MoM concentration for predicting GDM were 53.3% and 51.9%, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Lower maternal PAPP-A in early pregnancy can lead to glucose intolerance and increase the risk of subsequent GDM development. In addition, decreased serum concentration of PAPP-A is significantly correlated to lower birth weight and IUGR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-023-06155-7","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:02:52Z","timestamp":1702296172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Correlation between PAPP-A serum levels in the first trimester of pregnancy with the occurrence of gestational diabetes, a multicenter cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Sedigheh","family":"Borna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Ashrafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Eshraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Hivechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Hantoushzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"6155_CR1","doi-asserted-by":"publisher","unstructured":"Glucose metabolism tests and recurrent pregnancy loss: evidence from a systematic review and meta-analysis. https:\/\/doi.org\/10.1186\/s13098-022-00973-z.","DOI":"10.1186\/s13098-022-00973-z"},{"issue":"2","key":"6155_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/diaclin.33.2.97","volume":"33","author":"AD Association","year":"2015","unstructured":"Association AD. Standards of medical care in diabetes\u20142015 abridged for primary care providers. Clin Diabetes: Publication Am Diabetes Association. 2015;33(2):97.","journal-title":"Clin Diabetes: Publication Am Diabetes Association"},{"issue":"1","key":"6155_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4093\/dmj.2021.0335","volume":"46","author":"JH Moon","year":"2022","unstructured":"Moon JH, Jang HC. Gestational Diabetes Mellitus: diagnostic approaches and maternal-offspring Complications. Diabetes & Metabolism Journal. 2022;46(1):3\u201314.","journal-title":"Diabetes & Metabolism Journal"},{"issue":"6","key":"6155_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/OGX.0000000000000899","volume":"76","author":"I Tsakiridis","year":"2021","unstructured":"Tsakiridis I, Giouleka S, Mamopoulos A, Kourtis A, Athanasiadis A, Filopoulou D, et al. Diagnosis and management of gestational Diabetes Mellitus: an overview of National and International guidelines. Obstet Gynecol Surv. 2021;76(6):367\u201381.","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"6155_CR5","doi-asserted-by":"publisher","first-page":"e1191","DOI":"10.1210\/clinem\/dgaa899","volume":"106","author":"YT Wu","year":"2021","unstructured":"Wu YT, Zhang CJ, Mol BW, Kawai A, Li C, Chen L, et al. Early Prediction of Gestational Diabetes Mellitus in the Chinese Population via Advanced Machine Learning. J Clin Endocrinol Metab. 2021;106(3):e1191\u2013e205.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6155_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0301-2115(02)00480-3","volume":"109","author":"JL Bartha","year":"2003","unstructured":"Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Early diagnosis of gestational Diabetes Mellitus and prevention of diabetes-related Complications. Eur J Obstet Gynecol Reprod Biol. 2003;109(1):41\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"6155_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/01443615.2019.1615041","volume":"40","author":"R Caliskan","year":"2020","unstructured":"Caliskan R, Atis A, Aydin Y, Acar D, Kiyak H, Topbas F. PAPP-A concentrations change in patients with gestational Diabetes. J Obstet Gynaecol. 2020;40(2):190\u20134.","journal-title":"J Obstet Gynaecol"},{"issue":"1\u20132","key":"6155_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0014-5793(01)02760-0","volume":"504","author":"LS Laursen","year":"2001","unstructured":"Laursen LS, Overgaard MT, S\u00f8e R, Boldt HB, Sottrup-Jensen L, Giudice LC, et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 Independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 2001;504(1\u20132):36\u201340.","journal-title":"FEBS Lett"},{"issue":"12","key":"6155_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.placenta.2008.09.004","volume":"29","author":"SL Costa","year":"2008","unstructured":"Costa SL, Proctor L, Dodd JM, Toal M, Okun N, Johnson J-A, et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta. 2008;29(12):1034\u201340.","journal-title":"Placenta"},{"issue":"3","key":"6155_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/jp.2013.176","volume":"34","author":"A Odibo","year":"2014","unstructured":"Odibo A, Patel K, Spitalnik A, Odibo L, Huettner P. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol. 2014;34(3):186\u201391.","journal-title":"J Perinatol"},{"issue":"4","key":"6155_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","volume":"191","author":"L Dugoff","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric Complications: a population-based screening study (the FASTER trial). Am J Obstet Gynecol. 2004;191(4):1446\u201351.","journal-title":"Am J Obstet Gynecol"},{"key":"6155_CR12","doi-asserted-by":"publisher","first-page":"101330","DOI":"10.1016\/j.ghir.2020.101330","volume":"53\u201354","author":"J Frystyk","year":"2020","unstructured":"Frystyk J, Teran E, Gude MF, Bjerre M, Hjortebjerg R. Pregnancy-associated plasma proteins and Stanniocalcin-2 - novel players controlling IGF-I physiology. Growth Horm IGF Res. 2020;53\u201354:101330.","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"6155_CR13","first-page":"162","volume":"8","author":"E Rezaee","year":"2021","unstructured":"Rezaee E, Mohammadi F, Boozhmehrani MJ, Bagheri P. The prevalence of gestational Diabetes Mellitus in pregnant women referred to Amir al-Mu\u2019minin hospital of Gerash City, Fars Province, Iran. Int J Med Lab. 2021;8(3):162\u20137.","journal-title":"Int J Med Lab"},{"issue":"2","key":"6155_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tjog.2018.02.003","volume":"57","author":"ZH Talasaz","year":"2018","unstructured":"Talasaz ZH, Sadeghi R, Askari F, Dadgar S, Vatanchi A. First trimesters pregnancy-Associated plasma Protein-A levels value to Predict gestational Diabetes Mellitus: a systematic review and meta-analysis of the literature. Taiwan J Obstet Gynecol. 2018;57(2):181\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"6155_CR15","doi-asserted-by":"crossref","unstructured":"Yanachkova VE, Staynova R, Bochev I, Kamenov Z. Potential role of biochemical placentation markers - pregnancy associated plasma protein-A and human chorionic gonadotropin for early gestational Diabetes screening - a pilot study. Ginekol Pol. 2021.","DOI":"10.5603\/GP.a2021.0129"},{"issue":"1","key":"6155_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/uog.14870","volume":"46","author":"D Wright","year":"2015","unstructured":"Wright D, Silva M, Papadopoulos S, Wright A, Nicolaides KH. Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;46(1):42\u201350.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"6155_CR17","first-page":"584","volume":"22","author":"R Mohamad Jafari","year":"2019","unstructured":"Mohamad Jafari R, Masihi S, Barati M, Maraghi E, Sheibani S, Sheikhvatan M. Value of pregnancy-Associated plasma Protein-A for Predicting adverse pregnancy outcome. Arch Iran Med. 2019;22(10):584\u20137.","journal-title":"Arch Iran Med"},{"issue":"Suppl 1","key":"6155_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00508-018-1419-8","volume":"131","author":"A Kautzky-Willer","year":"2019","unstructured":"Kautzky-Willer A, Harreiter J, Winhofer-St\u00f6ckl Y, Bancher-Todesca D, Berger A, Repa A, et al. Gestational Diabetes Mellitus (update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):91\u2013102.","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"6155_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000486853","volume":"45","author":"AN Sweeting","year":"2019","unstructured":"Sweeting AN, Wong J, Appelblom H, Ross GP, Kouru H, Williams PF, et al. A novel early pregnancy risk prediction model for gestational Diabetes Mellitus. Fetal Diagn Ther. 2019;45(2):76\u201384.","journal-title":"Fetal Diagn Ther"},{"key":"6155_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/00365513.2014.936680","volume":"244","author":"K Spencer","year":"2014","unstructured":"Spencer K. Screening for Down syndrome. Scand J Clin Lab Invest Suppl. 2014;244:41\u20137.","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"1","key":"6155_CR21","first-page":"30","volume":"22","author":"QK Cheuk","year":"2016","unstructured":"Cheuk QK, Lo TK, Wong SF, Lee CP. Association between pregnancy-associated plasma protein-A levels in the first trimester and gestational Diabetes Mellitus in Chinese women. Hong Kong Med J. 2016;22(1):30\u20138.","journal-title":"Hong Kong Med J"},{"issue":"4","key":"6155_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1471-0528.2011.03253.x","volume":"119","author":"MD Savvidou","year":"2012","unstructured":"Savvidou MD, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH. First trimester maternal serum free \u03b2-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by Diabetes Mellitus. BJOG. 2012;119(4):410\u20136.","journal-title":"BJOG"},{"issue":"11","key":"6155_CR23","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3109\/14767058.2012.684170","volume":"25","author":"H Husslein","year":"2012","unstructured":"Husslein H, Lausegger F, Leipold H, Worda C. Association between pregnancy-associated plasma protein-A and gestational Diabetes requiring insulin treatment at 11\u201314 weeks of gestation. J Matern Fetal Neonatal Med. 2012;25(11):2230\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"6155_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/jdi.12672","volume":"9","author":"D Xiao","year":"2018","unstructured":"Xiao D, Chenhong W, Yanbin X, Lu Z. Gestational Diabetes Mellitus and first trimester pregnancy-associated plasma protein A: a case-control study in a Chinese population. J Diabetes Investig. 2018;9(1):204\u201310.","journal-title":"J Diabetes Investig"},{"issue":"6","key":"6155_CR25","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/jc.2014-4103","volume":"100","author":"G Wells","year":"2015","unstructured":"Wells G, Bleicher K, Han X, McShane M, Chan YF, Bartlett A, et al. Maternal Diabetes, large-for-gestational-age births, and first trimester pregnancy-Associated plasma Protein-A. J Clin Endocrinol Metab. 2015;100(6):2372\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6155_CR26","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1038\/s41598-020-61830-5","volume":"10","author":"A Fruscalzo","year":"2020","unstructured":"Fruscalzo A, Cividino A, Rossetti E, Maurigh A, Londero AP, Driul L. First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring. Sci Rep. 2020;10(1):5131.","journal-title":"Sci Rep"},{"issue":"16","key":"6155_CR27","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1080\/14767058.2017.1336759","volume":"31","author":"AN Sweeting","year":"2018","unstructured":"Sweeting AN, Wong J, Appelblom H, Ross GP, Kouru H, Williams PF, et al. A first trimester prediction model for gestational Diabetes utilizing aneuploidy and pre-eclampsia screening markers. J Matern Fetal Neonatal Med. 2018;31(16):2122\u201330.","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-06155-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T04:25:44Z","timestamp":1702441544000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-06155-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6155"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-06155-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of Tehran university of medical sciences (TUMS) approved this study, which adhered to the Hesinki declarations. All participants provided informed consent. (No: IR.TUMS.ILHC.1400.526).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"847"}}